Douglas G. Muse

home / authors / douglas-g-muse-0

Douglas G. Muse is consultant—€“Compendial Affairs, Eli Lilly & Co.

Articles

Understanding Concomitant Components in Pharmaceutical Excipients. Image: monsitj - stock.adobe.com

Understanding Concomitant Components in Pharmaceutical Excipients

Jennifer Putnam;Katherine L. Ullman;Priscilla Zawislak;David Schoneker;George Collins;Douglas G. Muse;Brian Carlin;Joseph Zeleznik;R. Christian Moreton
February 3rd 2021

Viewpoint: Continued dialogue among pharma stakeholders is needed to achieve consensus regarding excipient composition.

Additives and Processing Aids in Pharmaceutical Excipients

Additives and Processing Aids in Pharmaceutical Excipients

George Collins;Katherine Ulman;Douglas G. Muse;Joseph Zeleznik;Priscilla Zawislak;Elizabeth Tocce;R. Christian Moreton
October 1st 2019

This article seeks to encourage continued dialogue among stakeholders to achieve consensus regarding excipient additives and processing aids.

Third-Party Audits: Ensuring That Excipients Meet cGMP Requirements

Third-Party Audits: Ensuring That Excipients Meet cGMP Requirements

Ralph D. Lindblad;David B. Klug;Douglas G. Muse;Phyllis Walsh;Katherine L. Ulman;Priscilla Zawislak
September 1st 2018

Increasingly stringent audit requirements will make third-party accredited GMP audits critical for pharmaceutical excipients and raw materials.

Latest Updated Articles

Buy, Sell, Hold: Cell and Gene Therapy
Published: October 11th 2024 | Updated: October 18th 2024
Buy, Sell, Hold: Cell and Gene Therapy - Part 1
Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - © Artur - stock.adobe.com
Published: September 10th 2024 | Updated: September 18th 2024
CPHI Milan Announces 2024 CPHI Pharma Award Finalists
Published: August 21st 2024 | Updated: December 26th 2024
Pharmaceutical Technology Editorial Advisory Board
Leveraging Integrated Patient-Centric Innovations When Developing Today’s Biologics
Published: November 25th 2024 | Updated: December 26th 2024
Leveraging Integrated Patient-Centric Innovations When Developing Today’s Biologics
Drug Digest: Challenges and Triumphs in Next-Generation Biotherapeutic Development
Published: December 20th 2024 | Updated: December 26th 2024
Drug Digest: Challenges and Triumphs in Next-Generation Biotherapeutic Development
Europa Perspectives: Helping to Navigate the Regulatory System
Published: February 23rd 2024 | Updated: December 26th 2024
Europa Perspectives: Helping to Navigate the Regulatory System